Skip to main content

Advertisement

Table 3 AF patients in SR with discontinued warfarin treatment at study end versus the reference group

From: Effect of sinus rhythm restoration on markers of thrombin generation in atrial fibrillation

Variable AF patients (n = 13) Reference group (n = 49) p
Medical history
 Age (years) 59 ± 12 62 ± 0 0.298
 Sex (women/men) 4/9 20/29 0.509
 Body mass index (kg/m2) 25 ± 3 26 ± 4 0.253
 Hypertension 2 (15%) 18 (37%) 0.192
 Coronary heart disease 1 (8%) 2 (4%) 0.513
 Diabetes 1 (8%) 4 (8%) 1.0
 Chronic obstructive pulmonary disease 0 1 (2%) 1.0
 Current cigarette smoking 3 (23%) 7 (14%) 0.432
Medication
 Angiotensin receptor blocker/study drug 6 (46%) 13 (27%) 0.192
 Angiotensin-converting enzyme inhibitor 0 1 (2%) 1.0
 Beta-blockers 3 (23%) 4 (8%) 0.153
 Calcium channel blockers 3 (23%) 4 (8%) 0.153
 Diuretics 0 4 (8%) 0.571
 Statins 1 (8%) 11 (22%) 0.431
 Antiplatelet therapy 2 (15%) 5 (10%) 0.630
Blood pressure and heart rate
 Systolic blood pressure (mmHg) 129 ± 18 134 ± 15 0.326
 Diastolic blood pressure (mmHg) 78 ± 6 78 ± 8 0.779
 Ventricular heart rate (beats per minute) 59 ± 7 64 ± 10 0.072
  1. Clinical characteristics of atrial fibrillation patients maintaining sinus rhythm for 6 months without warfarin treatment at study end (n = 13) versus the reference group (n = 49).Values presented as mean ± standard deviation or number (%). Abbreviations: AF Atrial fibrillation; n Number of patients, SR Sinus rhythm